Literature DB >> 20643833

Registration of observational studies: is it time?

Rebecca J Williams1, Tony Tse, William R Harlan, Deborah A Zarin.   

Abstract

Mesh:

Year:  2010        PMID: 20643833      PMCID: PMC2952011          DOI: 10.1503/cmaj.092252

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  18 in total

1.  In defense of pharmacoepidemiology--embracing the yin and yang of drug research.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

2.  Replicating genotype-phenotype associations.

Authors:  Stephen J Chanock; Teri Manolio; Michael Boehnke; Eric Boerwinkle; David J Hunter; Gilles Thomas; Joel N Hirschhorn; Goncalo Abecasis; David Altshuler; Joan E Bailey-Wilson; Lisa D Brooks; Lon R Cardon; Mark Daly; Peter Donnelly; Joseph F Fraumeni; Nelson B Freimer; Daniela S Gerhard; Chris Gunter; Alan E Guttmacher; Mark S Guyer; Emily L Harris; Josephine Hoh; Robert Hoover; C Augustine Kong; Kathleen R Merikangas; Cynthia C Morton; Lyle J Palmer; Elizabeth G Phimister; John P Rice; Jerry Roberts; Charles Rotimi; Margaret A Tucker; Kyle J Vogan; Sholom Wacholder; Ellen M Wijsman; Deborah M Winn; Francis S Collins
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

3.  Commentary: on 'quality in epidemiological research: should we be submitting papers before we have the results and submitting more hypothesis generating research?'.

Authors:  Sander Greenland
Journal:  Int J Epidemiol       Date:  2007-10       Impact factor: 7.196

4.  Quality in epidemiological research: should we be submitting papers before we have the results and submitting more hypothesis-generating research?

Authors:  Debbie A Lawlor
Journal:  Int J Epidemiol       Date:  2007-09-17       Impact factor: 7.196

5.  Medicine. Moving toward transparency of clinical trials.

Authors:  Deborah A Zarin; Tony Tse
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

6.  Vision for a global registry of anticipated public health studies.

Authors:  Bernard C K Choi; John Frank; Jennifer S Mindell; Anna Orlova; Vivian Lin; Alain D M G Vaillancourt; Pekka Puska; Tikki Pang; Harvey A Skinner; Marsha Marsh; Ali H Mokdad; Shun-Zhang Yu; M Cristina Lindner; Gregory Sherman; Sandhi M Barreto; Lawrence W Green; Lawrence W Svenson; Peter Sainsbury; Yongping Yan; Zuo-Feng Zhang; Juan C Zevallos; Suzanne C Ho; Ligia M de Salazar
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

7.  Opportunities for enhancing the FDA guidance on pharmacovigilance.

Authors:  Bruce M Psaty; Jan P Vandenbroucke
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

8.  Public disclosure of clinical research.

Authors:  Ellen Strahlman; Frank Rockhold; Andrew Freeman
Journal:  Lancet       Date:  2009-03-25       Impact factor: 79.321

9.  Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

Authors:  Caroline A Sabin; Signe W Worm; Rainer Weber; Peter Reiss; Wafaa El-Sadr; Francois Dabis; Stephane De Wit; Matthew Law; Antonella D'Arminio Monforte; Nina Friis-Møller; Ole Kirk; Christian Pradier; Ian Weller; Andrew N Phillips; Jens D Lundgren
Journal:  Lancet       Date:  2008-04-02       Impact factor: 202.731

10.  Observational research, randomised trials, and two views of medical science.

Authors:  Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2008-03-11       Impact factor: 11.069

View more
  42 in total

1.  Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

Authors:  S V Wang; P Verpillat; J A Rassen; A Patrick; E M Garry; D B Bartels
Journal:  Clin Pharmacol Ther       Date:  2016-03       Impact factor: 6.875

Review 2.  Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis.

Authors:  Moshe Vardi; Robert W Yeh; Charles A Herzog; Wolfgang C Winkelmayer; Soko Setoguchi; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 8.237

3.  The Ontology of Clinical Research (OCRe): an informatics foundation for the science of clinical research.

Authors:  Ida Sim; Samson W Tu; Simona Carini; Harold P Lehmann; Brad H Pollock; Mor Peleg; Knut M Wittkowski
Journal:  J Biomed Inform       Date:  2013-11-13       Impact factor: 6.317

4.  Use of data from registered clinical trials to identify gaps in health research and development.

Authors:  Roderik F Viergever; Robert F Terry; Ghassan Karam
Journal:  Bull World Health Organ       Date:  2013-04-03       Impact factor: 9.408

Review 5.  A review of routinely collected data studies in urology: Methodological considerations, reporting quality, and future directions.

Authors:  Blayne Welk; Justin Kwong
Journal:  Can Urol Assoc J       Date:  2017 Mar-Apr       Impact factor: 1.862

6.  Poor outcome reporting in medical research; building practice on spoilt grounds.

Authors:  Styliani Mantziari; Nicolas Demartines
Journal:  Ann Transl Med       Date:  2017-05

7.  Improving confidence in observational studies : should statistical analysis plans be made publicly available?

Authors:  Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

8.  Automated analyses: Because we can, does it mean we should?

Authors:  Susan M Shortreed; Erica E M Moodie
Journal:  Stat Sci       Date:  2020-09-11       Impact factor: 2.901

9.  Increasing value and reducing waste: addressing inaccessible research.

Authors:  An-Wen Chan; Fujian Song; Andrew Vickers; Tom Jefferson; Kay Dickersin; Peter C Gøtzsche; Harlan M Krumholz; Davina Ghersi; H Bart van der Worp
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

Review 10.  Biomarker studies: a call for a comprehensive biomarker study registry.

Authors:  Fabrice Andre; Lisa M McShane; Stefan Michiels; David F Ransohoff; Douglas G Altman; Jorge S Reis-Filho; Daniel F Hayes; Lajos Pusztai
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.